グルタミノリシスとは? わかりやすく解説

Weblio 辞書 > 辞書・百科事典 > 百科事典 > グルタミノリシスの意味・解説 

グルタミノリシス

出典: フリー百科事典『ウィキペディア(Wikipedia)』 (2017/06/14 03:31 UTC 版)

グルタミノリシス(Glutaminolysis)あるいはグルタミン分解は、アミノ酸グルタミングルタミン酸アスパラギン酸CO2ピルビン酸乳酸アラニンクエン酸へと分解する一連の生化学反応である[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20]


  1. ^ a b Krebs, HA; Bellamy D (1960). “The interconversion of glutamic acid and aspartic acid in respiring tissues”. Biochem. J. 75: 523–529. PMC 1204504. PMID 14411856. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1204504/. 
  2. ^ a b Reitzer, LJ; Wice BM and Kennell D (1979). “Evidence that glutamine, not sugar, is the major energy source for cultured HeLa-cells”. J. Biol. Chem. 254 (8): 2669–2676. PMID 429309. 
  3. ^ a b Zielke, HR; Sumbilla CM, Sevdalian DA, Hawkins RL and Ozand PT (1980). “Lactate: a major product of glutamine metabolism by human diploid fibroblasts”. J. Cell. Physiol. 104 (3): 433–441. doi:10.1002/jcp.1041040316. PMID 7419614. 
  4. ^ a b Mc Keehan, WL (1982). “Glycolysis, glutaminolysis and cell proliferation”. Cell Bio. Int. Rep. 6 (7): 635–650. doi:10.1016/0309-1651(82)90125-4. PMID 6751566. 
  5. ^ a b c Moreadith RW, RW; Lehninger AL (1984). “The pathways of glutamate and glutamine oxidation by tumor cell mitochondria”. J. Biol. Chem. 259 (10): 6215–6221. PMID 6144677. 
  6. ^ a b Zielke, HR; Zielke CL and Ozand PT (1984). “Glutamine: a major energy source for cultured mammalian cells”. Fed. Proc. 43 (1): 121–125. PMID 6690331. 
  7. ^ a b Eigenbrodt, E; Fister P, Reinacher M (1985). “New perspectives on carbohydrate metabolism in tumor cells”. In: Regulation of Carbohydrate Metabolism, CRC Press, Boca Raton, Fl 2: 141–179. ISBN 0-8493-5263-0. 
  8. ^ a b Lanks, KW (1987). “End products of glucose and glutamine metabolism by L929 cells”. J. Biol. Chem. 262 (21): 10093–10097. PMID 3611053. 
  9. ^ a b Board, M; Humm S and Newsholme EA (1990). “Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells”. Biochem. J. 265 (2): 503–509. PMC 1136912. PMID 2302181. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1136912/. 
  10. ^ a b Medina, MA; Nunez de Castro I (1990). “Glutaminolysis and glycolysis interactions in proliferant cells”. Int. J. Biochem. 22 (7): 681–683. doi:10.1016/0020-711X(90)90001-J. PMID 2205518. 
  11. ^ a b Goossens, V; Grooten J and Fiers W (1996). “The oxidative metabolism of glutamine. A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells”. J. Biol. Chem. 271 (1): 192–196. doi:10.1074/jbc.271.1.192. PMID 8550558. 
  12. ^ a b Mazurek, S; Michel A and Eigenbrodt E (1997). “Effect of extracellular AMP on cell proliferation and metabolism of breast cancer cell lines with high and low glycolytic rates”. J. Biol. Chem. 272 (8): 4941–4952. doi:10.1074/jbc.272.8.4941. PMID 9030554. 
  13. ^ a b Eigenbrodt, E; Kallinowski F, Ott M, Mazurek S and Vaupel P (1998). “Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors”. Anticancer Res. 18 (5A): 3267–3274. PMID 9858894. 
  14. ^ a b Piva, TJ; McEvoy-Bowe E (1998). “Oxidation of glutamine in HeLa cells: role and control of truncated TCA cycles in tumour mitochondria”. J. Cell Biochem. 68 (2): 213–225. doi:10.1002/(SICI)1097-4644(19980201)68:2<213::AID-JCB8>3.0.CO;2-Y. PMID 9443077. 
  15. ^ Mazurek, S; Eigenbrodt E, Failing K and Steinberg P (1999). “Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells”. J. Cell. Physiol. 181 (1): 136–146. doi:10.1002/(SICI)1097-4652(199910)181:1<136::AID-JCP14>3.0.CO;2-T. PMID 10457361. 
  16. ^ a b Mazurek, S; Zwerschke W, Jansen-Dürr P and Eigenbrodt E (2001). “Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyuvate kinase type M2 and the glycolytic enzyme complex”. Biochem. J. 356 (Pt 1): 247–256. doi:10.1042/0264-6021:3560247. PMC 1221834. PMID 11336658. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1221834/. 
  17. ^ a b Aledo, JC (2004). “Glutamine breakdown in rapidly dividing cells: waste or investment ?”. BioEssays 26 (7): 778–785. doi:10.1002/bies.20063. PMID 15221859. 
  18. ^ a b Rossignol, R; Gilkerson R, Aggeler R, Yamagata K, Remington SJ and Capaldi RA (2004). “Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells”. Cancer Res. 64 (3): 985–993. doi:10.1158/0008-5472.CAN-03-1101. PMID 14871829. 
  19. ^ a b Mazurek, S (2007). “Tumor cell energetic metabolome”. In: Molecular System Bioenergetics (Saks, V ed.) Wiley-VCH, Weinheim, Germany: 521–540. ISBN 978-3-527-31787-5. 
  20. ^ DeBerardinis, RJ; Sayed N, Ditsworth D, Thompson CB (2008). “Brick by brick: metabolism and tumor growth”. Curr. Op. Gen. Dev. 18 (1): 54–61. doi:10.1016/j.gde.2008.02.003. PMC 2476215. PMID 18387799. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2476215/. 
  21. ^ Wolfrom, C; Kadhom N, Polini G, Poggi J, Moatti N and Gautier M (1989). “Glutamine dependency of human skin fibroblasts: modulation of hexoses”. Exp. Cell Res. 183 (2): 303–318. doi:10.1016/0014-4827(89)90391-1. PMID 2767153. 
  22. ^ Gardner, PR; Raineri I, Epstein LB and White CW (1995). “Superoxide radical and iron modulate aconitase activity in mammalian cells”. J. Biol. Chem. 270 (22): 13399–13405. doi:10.1074/jbc.270.22.13399. PMID 7768942. 
  23. ^ Kim, KH; Rodriguez AM, Carrico PM and Melendez JA (2001). “Potential mechanisms for the inhibition of tumor cell growth by manganese superoxide dismutase”. Antioxid. Redox. Signal. 3 (3): 361–373. doi:10.1089/15230860152409013. PMID 11491650. 
  24. ^ Matsuno, T; Goto I (1992). “Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma”. Cancer Res. 52 (5): 1192–1194. PMID 1346587. 
  25. ^ Aledo, JC; Segura JA, Medina MA, Alonso FJ, Nunez de Castro I and Marquez J (1994). “Phosphate-activated glutaminase expression during tumor development”. FEBS Lett. 341 (1): 39–42. doi:10.1016/0014-5793(94)80236-X. PMID 8137919. 
  26. ^ a b Lobo, C; Ruiz-Bellido MA, Aledo JC, Marquez J, Nunez De Castro I and Alonso FJ (2000). “Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells”. Biochem. J. 348 (2): 257–261. doi:10.1042/0264-6021:3480257. PMC 1221061. PMID 10816417. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1221061/. 
  27. ^ Mazurek, S; Grimm H, Oehmke M, Weisse G, Teigelkamp S and Eigenbrodt E (2000). “Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells”. Anticancer Res. 20 (6D): 5151–5154. PMID 11326687. 
  28. ^ Turowski, GA; Rashid Z, Hong F, Madri JA and Basson MD (1994). “Glutamine modulates phenotype and stimulates proliferation in human colon cancer cell lines”. Cancer Res. 54 (22): 5974–5980. PMID 7954430. 
  29. ^ Spittler, A; Oehler R, Goetzinger P, Holzer S, Reissner CM, Leutmezer J, Rath V, Wrba F, Fuegger R, Boltz-Nitulescu G and Roth E (1997). “Low glutamine concentrations induce phenotypical and functional differentiation of U937 myelomonocytic cells”. J. Nutr. 127 (11): 2151–2157. PMID 9349841. 
  30. ^ Matsuno, T (1991). “Pathway of glutamate oxidation and its regulation in HuH13 line of human hepatoma cells”. J. Cell. Physiol. 148 (2): 290–294. doi:10.1002/jcp.1041480215. PMID 1679060. 
  31. ^ Parlo, RA; Coleman PS (1984). “Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria. The truncated Krebs cycle and other metabolic ramifications of mitochondrial membrane cholesterol”. J. Biol. Chem. 259 (16): 9997–10003. PMID 6469976. 
  32. ^ Mazurek, S; Grimm H, Boschek CB, Vaupel P and Eigenbrodt E (2002). “Pyruvate kinase type M2: a crossroad in the tumor metabolome”. Brit. J. Nutr. 87: S23–S29. doi:10.1079/BJN2001455. PMID 11895152. 
  33. ^ Eck, HP; Drings P and Dröge W (1989). “Plasma glutamate levels, lymphocyte reactivity and death in patients with bronchial carcinoma”. J. Cancer Res. Clin. Oncol. 115 (6): 571–574. doi:10.1007/BF00391360. PMID 2558118. 
  34. ^ Grimm, H; Tibell A, Norrlind B, Blecher C, Wilker S, and Schwemmle K (1994). “Immunoregulation by parental lipids: impact of the n-3 to n-6 fatty acid ratio”. J. Parenter. Enteral. Nutr. 18 (5): 417–421. doi:10.1177/0148607194018005417. PMID 7815672. 
  35. ^ Jiang, WG; Bryce RP and Hoorobin DF (1998). “Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications”. Crit. Rev. Oncol. Hematol. 27 (3): 179–209. doi:10.1016/S1040-8428(98)00003-1. PMID 9649932. 


「グルタミノリシス」の続きの解説一覧



英和和英テキスト翻訳>> Weblio翻訳
英語⇒日本語日本語⇒英語
  

辞書ショートカット

すべての辞書の索引

「グルタミノリシス」の関連用語

グルタミノリシスのお隣キーワード
検索ランキング

   

英語⇒日本語
日本語⇒英語
   



グルタミノリシスのページの著作権
Weblio 辞書 情報提供元は 参加元一覧 にて確認できます。

   
ウィキペディアウィキペディア
All text is available under the terms of the GNU Free Documentation License.
この記事は、ウィキペディアのグルタミノリシス (改訂履歴)の記事を複製、再配布したものにあたり、GNU Free Documentation Licenseというライセンスの下で提供されています。 Weblio辞書に掲載されているウィキペディアの記事も、全てGNU Free Documentation Licenseの元に提供されております。

©2024 GRAS Group, Inc.RSS